Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:LVGO

Livongo Health (LVGO) Stock Price, News & Analysis

Livongo Health logo

About Livongo Health Stock (NASDAQ:LVGO)

Key Stats

Today's Range
$139.77
$139.77
50-Day Range
$136.67
$148.08
52-Week Range
$18.76
$151.05
Volume
N/A
Average Volume
3.04 million shs
Market Capitalization
$14.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

Receive LVGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Livongo Health and its competitors with MarketBeat's FREE daily newsletter.

LVGO Stock News Headlines

Define Ventures Appoints Bruce Broussard as Venture Partner
Financial Prophecy
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
David P Fialkow's Net Worth
See More Headlines

LVGO Stock Analysis - Frequently Asked Questions

Livongo Health, Inc. (NASDAQ:LVGO) announced its quarterly earnings data on Wednesday, October, 28th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.05 by $0.11. The company had revenue of $106.10 million for the quarter, compared to the consensus estimate of $95.57 million. Livongo Health had a negative net margin of 12.20% and a positive trailing twelve-month return on equity of 0.29%.

Livongo Health (LVGO) raised $230 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 10,700,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Tesla (TSLA), Meta Platforms (META), Block (SQ), PayPal (PYPL) and Salesforce (CRM).

Company Calendar

Last Earnings
10/28/2020
Today
11/08/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer Programming, Data Processing, & Other Computer Related
Sub-Industry
N/A
Current Symbol
NASDAQ:LVGO
CIK
N/A
Fax
N/A
Employees
471
Year Founded
N/A

Profitability

Net Income
$-55,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$170.20 million
Book Value
$5.37 per share

Miscellaneous

Free Float
N/A
Market Cap
$14.20 billion
Optionable
Not Optionable
Beta
1.81
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:LVGO) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners